Consensus Qiagen N.V. Deutsche Boerse AG

Equities

QIA

NL0015001WM6

Market Closed - Deutsche Boerse AG Other stock markets 05:03:19 07/06/2024 pm IST			5-day change	1st Jan Change
40.95 ^EUR	-0.02%		+4.36%	+1.05%

06/06	Qiagen Scraps NeuMoDx 96, 288 Molecular Systems; Raises 2024 Adjusted Earnings Outlook	MT
06/06	Qiagen to Discontinue NeuMoDx Integrated PCR Testing System	CI

Evolution of the average Target Price on Qiagen N.V.

Price target over the last 5 years

History of analyst recommendation changes

23933d6d041f34e56d58e48.1nU3o5daOZbivGWzi_z1MD79WQJNCvy-jv-336td9ss.5Sxdx94yUsO68lPJ-qiUfm3EGEd4PJTS3ZfVrfgbt_yELwP6pRcN_4PMDg~32f934e5604fa4163c58bb1e0d7123a4

Analyst Recommendations on Qiagen N.V.

QIAGEN NV : Berenberg maintains a Buy rating	21/05	ZD
QIAGEN NV : Berenberg reaffirms its Buy rating	30/04	ZD
QIAGEN : A decent start to 2024; guidance unchanged	30/04
QIAGEN NV : Deutsche Bank reiterates its Buy rating	30/04	ZD
QIAGEN NV : Jefferies remains Neutral	30/04	ZD
QIAGEN NV : UBS remains Neutral	30/04	ZD
QIAGEN NV : UBS remains Neutral	30/04	ZD
QIAGEN NV : UBS sticks Neutral	30/04	ZD
QIAGEN NV : Deutsche Bank reiterates its Buy rating	16/04	ZD
QIAGEN NV : UBS reaffirms its Neutral rating	01/03	ZD
Morgan Stanley Upgrades Qiagen to Overweight From Equalweight, Adjusts Price Target to $49.48 From $51	16/02	MT
QIAGEN NV : Berenberg reiterates its Buy rating	16/02	ZD
QIAGEN NV : Deutsche Bank remains its Buy rating	14/02	ZD
QIAGEN NV : JP Morgan reiterates its Buy rating	08/02	ZD
QIAGEN NV : UBS reiterates its Neutral rating	08/02	ZD
QIAGEN : In line Q4; routine business prospects remain intact	07/02
QIAGEN NV : Gets a Neutral rating from UBS	07/02	ZD
QIAGEN NV : Berenberg reaffirms its Buy rating	07/02	ZD
QIAGEN NV : DZ Bank gives a Buy rating	07/02	ZD
QIAGEN NV : Deutsche Bank reiterates its Buy rating	07/02	ZD
BofA Securities Raises Price Target on Qiagen to $55 From $52, Maintains Buy Rating	29/01	MT
QIAGEN NV : Buy rating from Deutsche Bank	26/01	ZD
QIAGEN NV : Berenberg reiterates its Buy rating	18/01	ZD
QIAGEN NV : Morgan Stanley keeps its Buy rating	08/01	ZD
QIAGEN NV : UBS reiterates its Neutral rating	05/01	ZD

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

44.85 USD

Average target price

50.14 USD

Spread / Average Target

+11.79%

High Price Target

60 USD

Spread / Highest target

+33.78%

Low Price Target

42.5 USD

Spread / Lowest Target

-5.24%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Qiagen N.V.

BERENBERG	Odysseas Manesiotis
alphavalue	Anas Patel
DEUTSCHE BANK RESEARCH	Falko Friedrichs
UBS	Dan Leonard
JEFFERIES	Peter Welford
Morgan Stanley
DZ BANK	Sven Kürten
JPMORGAN	Casey Woodring
BofA Securities
Wells Fargo Securities
Goldman Sachs
JPMorgan Chase
Baird
Invest Securities
Citigroup
DEUTSCHE BANK	Falko Friedrichs
KEPLER CHEUVREUX	Oliver Reinberg
Redburn
NORDLB	Thorsten Strauß
WARBURG RESEARCH	Ulrich Huwald
INDEPENDENT RESEARCH	Tobias Gottschalt
BARCLAYS	Jack Meehan
COMMERZBANK	Daniel Wendorff
EVERCORE ISI

Ratings for Qiagen N.V.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar